Myriad Genetics

MYGN

MYGN
Myriad Genetics Stock Quote
$28.43 -$0.19 -0.7%
BATS BZX Real Time Price as of January 27, 2020, 4:30 p.m. EST View Interactive MYGN Charts

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

News & Analysis: Myriad Genetics

The Fool has written over 200 articles on Myriad Genetics.

All

Market Moves

Earnings








3 Cancer Treatment Stocks to Buy Right Now

Cancer is one of the toughest diseases to fight, and these companies are playing a great role in helping people combat it.


Myriad Genetics Limps Into Fiscal 2020

A sluggish end to fiscal 2019 and weaker-than-expected guidance for the year ahead aren't instilling much confidence in investors.



Interactive Chart